LeMaitre to Present at Upcoming Investor Conferences in August
Get Alerts LMAT Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.4%
EPS Growth %: +12.9%
Join SI Premium – FREE
BURLINGTON, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced today that it is participating in two upcoming investor conferences in August.
JJ Pellegrino, Chief Financial Officer, will participate in the 8th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday, August 14, 2023.
David Roberts, President, will present at the UBS MedTech, Tools and Genomics Summit at the Waldorf Astoria in Dana Point, CA. The company’s presentation is scheduled at 1:00 PM PT (4:00 PM ET).
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
Contact:Sandra MillarLeMaitre Vascular, Inc.+1-781-425-1686[email protected]
Source: LeMaitre Vascular, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bonchon Acquired by Minor Food and Serruya Private Equity
- EverPass Media Expands NFL Offering Through Multi-Year Agreement with Netflix
- Doxim Recognized in DOCUMENT Strategy Media's HOT COMPANIES 2026-27
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
UBS, Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share